Jim Cramer Explains Why Merck (MRK) Is His Fantasy Defense Stock Jim Cramer's enthusiasm for pharmaceutical giant Merck & Co. , Inc.
(NYSE:MRK) as a "fantasy defense stock" may be music to the ears of investors, but it raises important questions about the broader economy and the vulnerabilities of corporate America.
Merck's supposed defensiveness is largely due to its reliance on established products, particularly Keytruda, which has become a cash cow for the company.